In this report,perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perphenazine is considered a medium-potency antipsychotic.
In the last several years, Global market of Perphenazine developed slowly, with an average growth rate of 0.4%. In 2017, Global Revenue of Perphenazine is 95.46 M USD; the actual sales are about 12750 K Unit.
Perphenazine can be divided into two categories-- oral forms type and injectable solution type. Oral forms’ sales market share accounted for the highest proportion, with a figure of 98.17% in 2017, food grade account for 1.83%.
The global average price of Perphenazine is in the increasing trend, from 6.95 USD/Unit in 2012 to 7.08 USD/Unit in 2016. With the situation of global economy, prices will still be in increasing trend in the following five years.
XYZ research center data shows that United States is the biggest contributor to the Perphenazine revenue market, accounted for 45.89% of the total global market with a revenue of 41.66 million USD in 2016, followed by Europe, 15.62% with a revenue of 14.18 million USD.
Teva is the largest company in the global Perphenazine market, accounted for 46.38% of the revenue market share in 2017, followed by Sandoz and Endo, accounted for 18.82% and 13.23% of the revenue market share in 2017.
Geographically, global Perphenazine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Shandong Boshan Pharma
On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Perphenazine for each application, including
Production, consumption, revenue, market share and growth rate are the key targets for Perphenazine from 2014 to 2026 (forecast) in these regions
If you have any special requirements, please let us know and we will offer you the report as you want.